Leafwell’s Post

At Leafwell, we are dedicated to advancing the understanding and application of medical cannabis. With one of the largest patient databases in the world, we are committed to contributing to research in the medical cannabis field to improve patient outcomes and access to lifesaving care. Our latest study, published earlier this week, draws on data from 2019-2023 and provides crucial insights into medical cannabis use among individuals under 21. Here are some of the key findings from our study: 👥 Minors vs. Young Adults: Our research reveals that minors constitute a small percentage (around 1%) of medical cannabis users. Within our sample, only 5.7% were minors, with the remaining 94.3% being 18-to-20-year-olds. 📍 States with the Most Minor Patients: The highest counts of minor patients were found in California, Ohio, and Oregon. When considering rates per 100,000 population, Maine, Oregon, and New Hampshire show the highest prevalence of minor patients. 🏥 Medical Conditions: Anxiety emerged as the most commonly reported primary condition, followed by chronic pain, and nausea/vomiting. Notably, higher percentages of young adults reported chronic pain, depression, and insomnia compared to minors. Conversely, conditions such as cancer, epilepsy, PTSD, and other miscellaneous conditions were reported at higher percentages among minors. 🔬 The Need for Further Research: There remains a significant need for continued research to address gaps in pediatric-specific evidence. Understanding how medical cannabis affects individuals under 20 is crucial for improving patient care and informing regulatory frameworks. Leafwell is proud to fund and support research efforts that pave the way for better healthcare solutions and innovations. Read more here: https://lnkd.in/gzAQbVWn Mitchell L. Doucette, PhD, MS Dr. June Chin Emily Fisher Luke Macfarlan Dipak Hemraj #MedicalCannabis #PediatricResearch #LeafwellResearch

The Leafwell team had a blast at Flower Expo this week. We were honored to be the expo's official medical cannabis card provider! We connected with partners like Curaleaf and Berkshire Roots (who we absolutely love), and enjoyed engaging with so many new faces. The sense of community at this year's expo was palpable. We love any opportunity to share our knowledge about medical cannabis and discuss how Leafwell can support individuals on their wellness journeys. A huge thank you to the organizers for putting together such a phenomenal event! We'll see you at the next 👀 #CannabisConference #B2B #Parnterships #Leafwell

We love our Patient Care team! Meet Estefany Rugerio, one of Leafwell’s Patient Care team leads. She works directly with physicians and patients to ensure smooth operation throughout the application and certification process. If necessary, she talks to the state on behalf of the patient state to resolve certification issues. At Leafwell, the most important thing is ensuring patients get the best quality care possible. The Patient Care team is integral to this! Learn more about her contributions to an exceptional patient experience and her journey to the cannabis industry: https://lnkd.in/gZ2MDGFm #CannabisIndustry #Leafwell #patientcare #patientsupport

We were at #CANNRA in Minneapolis this week! Cannabis Regulators Association (CANNRA) is a nonpartisan, nonprofit 501(c)(4) association of government agencies engaged in cannabis and cannabinoid regulation. CANNRA's mission? To convene, educate, and support governmental jurisdictions responsible for implementing cannabis and cannabinoid policies and regulations. They achieve this by bringing together diverse stakeholders from the cannabis, cannabinoid, and hemp industries to discuss key regulatory and policy issues with CANNRA members. Leafwell's Research Director Mitchell L. Doucette, PhD, MS, was on a panel at this morning's breakout session, "How do Policies Affect Patients? Scientific and Policy Insights on Patient Outcomes and Access to Medical Cannabis and Cannabinoids." Joining him on the panel were notable experts: ➡ Steph Sherer, Executive Director of Americans For Safe Access ➡ Jordan Tishler MD, President of the Association of Cannabinoid Specialists ➡ Professor Ryan Vandrey, PhD, from The Johns Hopkins University Their insightful discussion shed light on the critical impact of policies on patient outcomes and access to medical cannabis. Looking forward to more conversations like these! #CannabisPolicy #PatientOutcomes #CannabisConference

Leafwell will be in Massachusetts next week at the Flower Expo as their official medical card provider. 🥇We are the #1 Medical Card Telehealth platform in the United States with over 400,000 patients. 🪪 We offer the best care, best value guaranteed. 📈 We drove $75 million in partner revenue in 2023 Stop by and say hi! #FlowerExpo #CannabisConference